- Home
- FBIOP vs MTSI Comparison
FBIOP vs MTSI Comparison
Compare FBIOP & MTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- MTSI
- Stock Information
- Founded
- FBIOP N/A
- MTSI 1950
- Country
- FBIOP United States
- MTSI United States
- Employees
- FBIOP 186
- MTSI N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- MTSI Semiconductors
- Sector
- FBIOP Health Care
- MTSI Technology
- Exchange
- FBIOP Nasdaq
- MTSI Nasdaq
- Market Cap
- FBIOP N/A
- MTSI N/A
- IPO Year
- FBIOP N/A
- MTSI 2012
- Fundamental
- Price
- FBIOP $6.37
- MTSI $132.24
- Analyst Decision
- FBIOP
- MTSI Strong Buy
- Analyst Count
- FBIOP 0
- MTSI 10
- Target Price
- FBIOP N/A
- MTSI $128.00
- AVG Volume (30 Days)
- FBIOP N/A
- MTSI 541.0K
- Earning Date
- FBIOP N/A
- MTSI 01-30-2025
- Dividend Yield
- FBIOP N/A
- MTSI N/A
- EPS Growth
- FBIOP N/A
- MTSI N/A
- EPS
- FBIOP N/A
- MTSI 1.04
- Revenue
- FBIOP N/A
- MTSI $729,578,000.00
- Revenue This Year
- FBIOP N/A
- MTSI $26.74
- Revenue Next Year
- FBIOP N/A
- MTSI $10.96
- P/E Ratio
- FBIOP N/A
- MTSI $127.45
- Revenue Growth
- FBIOP N/A
- MTSI 12.52
- 52 Week Low
- FBIOP N/A
- MTSI $79.25
- 52 Week High
- FBIOP N/A
- MTSI $143.90
- Technical
- Relative Strength Index (RSI)
- FBIOP 51.85
- MTSI 56.80
- Support Level
- FBIOP $6.40
- MTSI $136.46
- Resistance Level
- FBIOP $7.10
- MTSI $141.88
- Average True Range (ATR)
- FBIOP 0.72
- MTSI 3.91
- MACD
- FBIOP -0.01
- MTSI -0.56
- Stochastic Oscillator
- FBIOP 50.66
- MTSI 47.31
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.